Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the potential difference in Fasting Plasma Glucose (FPG)
lowering efficacy between the two DPP-4 inhibitors vildagliptin and sitagliptin, both after a
two weeks treatment on top of metformin.